Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb Pilot Study of Atazanavir/ritonavir Monotherapy Maintenance in Virologically Suppressed HIV-infected Patients
2005-005119-76Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of atazanavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Primary endpoint: Proportion of subjects with virologic rebound or treatment discontinuation at Week 48. Started Mar 2010; status: completed.
02
Drugs
atazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-005119-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005119-76.